ClinicalTrials.gg
Status unknownNCT06589453D-NAMUpdated Oct 17, 2024

Evaluation of Nasal Elevator Versus Grayson's Nasal Stent with D-NAM Appliance on Nasolabial Esthetics in Bilateral Cleft Lip and Palate Infants

A Phase 1 interventional study of Nasal elevator with digital nasoalveolar molding in bilateral cleft lip and palate infants and Nasal stent with digital nasoalveolar molding in bilateral cleft lip and palate infants in Cleft Lip and Cleft Palate, sponsored by Cairo University. Status unknown. Open to participants aged 1 Day to 1 Month. Per ClinicalTrials.gov, last updated 2024-10-17.

Sponsored by Cairo University · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
1 Day to 1 Month
Sex
All
01

Study summary

Newborns with bilateral cleft lip/ palate will be treated pre-surgically by either nasal elevator or Grayson nasal stent in conjunction with digital nasoalveolar molding (D-NAM) appliance in order to evaluate their effect on the nasolabial esthetics.

Read the detailed description

The aim of this trial is to evaluate and compare the short-term effect of nasal elevator with Grayson nasal stent in conjunction with digital nasoalveolar molding appliances at 2 stages T1 (Before NAM therapy), and T2 (After NAM therapy) as regards nasolabial esthetics and maxillary arch changes.

Newborns with Bilateral cleft lip/ palate will be allocated randomly into two groups: the first group will receive nasal elevator with digital nasoalveolar molding appliance while the second group will receive Grayson nasal stent with digital nasoalveolar molding appliance. The follow-up period will be 4-6 months till surgical lip closure. The nasolabial esthetics will be assessed using facial scans and 2D photographs, while changes in the maxillary arch will be assessed by digital maxillary models.

02

Conditions studied

  • Cleft Lip and Cleft Palate

Keywords

  • Cleft lip and palate
03

In context

Cleft Lip

167 studies on the registry are indexed under Cleft Lip; 53 are open to participants now.

This study's planned enrollment of 20 is below the median of 30 across 117 interventional studies indexed under Cleft Lip.

Browse Cleft Lip studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 1 Month
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-syndromic Infants with complete BCLP infants
  • Infants less than 1 month of age.
  • Males and females.
  • Infants with displaced premaxilla
  • Patients whose parents provided written consent for the study.

Exclusion criteria

Exclusion Criteria:

  • Patients above 1 month of age.
  • Syndromic and systemically ill infants.
  • Patients with unilateral cleft lip and palate.
  • Incomplete Cleft lip or Simonart band (soft tissue bridge at the cleft side).
  • Medically compromised patients
  • Patien parents/guardians who will be unwilling to go through the Naso-alveolar molding (NAM) therapy.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Nasal stent with Digital Nasoalveolar molding

    Device: Nasal stent with digital nasoalveolar molding in bilateral cleft lip and palate infants

  • Experimental
    Nasal elevator with Digital Nasoalveolar molding

    Nasal elevator will be used in conjunction with digital nasoalveolar molding appliance to improve nasolabial esthetics in bilateral cleft lip and palate infants.

    Device: Nasal elevator with digital nasoalveolar molding in bilateral cleft lip and palate infants

Interventions

  • DeviceNasal elevator with digital nasoalveolar molding in bilateral cleft lip and palate infants

    This is a unique nasal elevator aiming to improve nasolabial esthetics in conjunction with digital nasoalveolar molding appliance when used in bilateral cleft lip and palate infants.

  • DeviceNasal stent with digital nasoalveolar molding in bilateral cleft lip and palate infants

    Nasal stent that is used in conjunction with digital nasoalveolar molding in bilateral cleft lip and palate infants

06

What researchers measure

Primary outcomes

  1. Nasolabial esthetics

    Columellar length is to be measured in millimeters digitally using facial scans before and after Nasoalveolar Molding therapy.

    Time frame: 4-6 months

Secondary outcomes

  1. Maxillary arch changes

    Maxillary arch changes will be assessed in millimeters using maxillary digital models.

    Time frame: 4-6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2024; primary completion for Mar 2026, 16 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2024
First posted
Sep 19, 2024
StartEst.
Nov 1, 2024
Primary completionEst.
Mar 30, 2026
CompletionEst.
Oct 1, 2026
Last update
Oct 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06589453
Lead sponsor
Cairo University
Responsible party
: Donia Ayman Ahmed Ezzeldin ElSayed (Assistant lecturer at Orthodontic Department, Cairo University, Cairo University) — Principal investigator
First posted
Sep 19, 2024
Start date
Nov 1, 2024 (estimated)
Primary completion
Mar 30, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Oct 17, 2024

Study contacts

Donia Ayman Ahmed Ezzeldin, PhD
Contact
donia.ayman@dentistry.cu.edu.eg
00201001200089
Mohamed Abd-El-Ghafour Omar
Contact
m.abdelghafour@dentistry.cu.edu.eg
00201007433288

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion